KPMA calls for scrapping of economic effectiveness evaluation system over medicines

Published: 2008-09-04 06:58:00

Updated: 2008-09-04 06:58:00

The Korea Pharmaceutical Manufacturers Association (KPMA) has urged the government not to evaluate the economic effectiveness of conventional medicines to reduce their prices on a regular basis.

In a statement delivered to President Lee Myung-bak on August 26, the KPMA claims that the new drug...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK